ALPS Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-49,166
Closed -$1.89M 1161
2023
Q2
$1.89M Buy
49,166
+5,786
+13% +$222K 0.02% 321
2023
Q1
$1M Buy
43,380
+39
+0.1% +$903 0.01% 469
2022
Q4
$1.14M Buy
43,341
+9,033
+26% +$237K 0.01% 429
2022
Q3
$674K Sell
34,308
-2,200
-6% -$43.2K 0.01% 546
2022
Q2
$639K Sell
36,508
-17,856
-33% -$313K 0.01% 541
2022
Q1
$889K Sell
54,364
-6,857
-11% -$112K 0.01% 323
2021
Q4
$999K Buy
61,221
+6,318
+12% +$103K 0.01% 361
2021
Q3
$701K Sell
54,903
-3,858
-7% -$49.3K 0.01% 445
2021
Q2
$830K Sell
58,761
-17,503
-23% -$247K 0.01% 426
2021
Q1
$1.19M Buy
76,264
+47,323
+164% +$735K 0.01% 381
2020
Q4
$459K Buy
28,941
+8,240
+40% +$131K 0.01% 511
2020
Q3
$252K Sell
20,701
-1,355
-6% -$16.5K ﹤0.01% 768
2020
Q2
$255K Buy
+22,056
New +$255K ﹤0.01% 632
2019
Q4
Sell
-31,960
Closed -$169K 867
2019
Q3
$169K Sell
31,960
-1,545
-5% -$8.17K ﹤0.01% 821
2019
Q2
$258K Sell
33,505
-4,853
-13% -$37.4K ﹤0.01% 863
2019
Q1
$763K Buy
38,358
+1,656
+5% +$32.9K 0.01% 393
2018
Q4
$484K Buy
36,702
+8,721
+31% +$115K ﹤0.01% 489
2018
Q3
$1.03M Buy
27,981
+5,130
+22% +$188K 0.01% 393
2018
Q2
$800K Buy
22,851
+2,837
+14% +$99.3K 0.01% 398
2018
Q1
$931K Buy
20,014
+3,478
+21% +$162K 0.01% 326
2017
Q4
$620K Buy
16,536
+1,840
+13% +$69K ﹤0.01% 377
2017
Q3
$783K Buy
14,696
+2,075
+16% +$111K 0.01% 285
2017
Q2
$719K Buy
12,621
+1,062
+9% +$60.5K 0.01% 285
2017
Q1
$621K Sell
11,559
-1,354
-10% -$72.7K ﹤0.01% 276
2016
Q4
$736K Sell
12,913
-3,581
-22% -$204K 0.01% 236
2016
Q3
$1.03M Sell
16,494
-1,659
-9% -$103K 0.01% 224
2016
Q2
$1.03M Buy
18,153
+3,932
+28% +$222K 0.01% 206
2016
Q1
$911K Sell
14,221
-2,436
-15% -$156K 0.01% 190
2015
Q4
$2.34M Sell
16,657
-2,826
-15% -$398K 0.02% 165
2015
Q3
$18.9K Buy
19,483
+7,778
+66% +$7.53K 0.02% 173
2015
Q2
$1.78M Buy
+11,705
New +$1.78M 0.02% 174